1 Department of Cardiothoracic Surgery, Suez Canal University, Ismailia, Egypt. 2 Department of Anatomy, Suez Canal University, Ismailia, Egypt. 3 Cardiac Science Department, Al-Hada Armed Forces ...

Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...

Highlights in poststroke care from ISC 2026 include benefits of asundexian, promise of an investigational revascularization ...

The vast majority of patients presenting with type 1 NSTEMI undergo invasive coronary angiography in the US, with most receiving PCI, according to an analysis presented this week at CRT 2026. But as ...

Perioperative morbidity and mortality were reduced with off-pump vs on-pump coronary artery bypass grafting, though survival ...

There are no evidence‐based resources guiding the perioperative management of patients with moyamoya syndrome who are undergoing revascularization surgery. We investigated practice patterns among a ...

Please provide your email address to receive an email when new articles are posted on . An investigational stent retriever device was highly effective in restoring blood flow in distal vessel ischemic ...

Aplagon has dosed the first patient in its phase 2a HEALING clinical trial evaluating APAC, a first‑in‑class treatment for thrombo‑inflammatory diseases, in people with peripheral arterial occlusive ...

Immediate revascularization of nonculprit lesions in patients with STEMI was not superior compared with deferred percutaneous coronary intervention of nonculprit lesions out to 3 years, researchers ...

At 3 years, Agent still outshined uncoated balloons. Registry data show rapid uptake of the DCB in the year after its FDA approval.

Black patients undergoing peripheral vascular intervention (PVI) were more likely to be younger, have comorbidities and lower socioeconomic status, and were less likely to undergo surgical or repeat ...

Today at the Cardiovascular Research Technologies (CRT) annual conference taking place in Washington, DC, Dr. Christopher ...